This report provides exclusive insights into the COVID-19 impact on the Allergy Vaccine Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Allergy Vaccine Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Allergy Vaccine Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on the allergy
vaccine market provides an in-depth analysis of segments and sub-segments in the
global as well as regional allergy vaccine market. The study also highlights
the impact of drivers, restraints, and macro indicators on the global and
regional allergy vaccine market over the short term as well as long term. The
report is a comprehensive presentation of trends, forecast and dollar values of the global allergy vaccine market. According to the report, the global allergy
vaccine market is projected to grow at a healthy CAGR over the forecast period
The condition caused by the misguided reaction of the immune
system to harmless or foreign substances i.e allergens is known as allergy. It
can be due to food, inject into the body or due to inhalation into the lungs.
Common types of allergies include allergic asthma, drug allergy, food allergy,
allergic rhinitis, etc. Allergy caused by allergens may lead to symptoms such
as vomiting, sneezing, peeling skin, running nose and itchy eyes. In extreme
conditions, it may also cause rashes, breathing trouble, low blood pressure,
and hives. Few allergies like anaphylaxis can be life-threatening.
Growing prevalence of the allergic disease is one of the major
cause driving the growth of allergy vaccine market. Based on the report
published by AAFA more than 50 million Americans are suffering from various
types of allergies each year and it has become the 6th leading cause of chronic
illness in the United States. furthermore, a report published by World Allergy
Organization (WAO) Allergies and related diseases including asthma,
rhinosinusitis, atopic dermatitis and life-threatening food, drug, and stinging
insect allergies affects at least 30% of the population and nearly 80% of
families. Moreover, new research activities for the development of allergy
vaccines by private and government industries are also contributing to the
growth of the market. On the other hand, high costs associated with the
vaccines and the presence of limited manufactures can hamper the growth of the
market. However, growing awareness about the allergy disease and their
treatment among the people globally will provide a better opportunity for the
growth of the market in the forecast period.
Geographically the allergy market is divided into North America,
Europe, Asia-Pacific, and RoW. North America is expected to dominate the market
in the forecast period, followed by Europe. Growing cases of allergy diseases
in these regions will contribute to the high demand for allergy vaccines in the
future period. The Asia Pacific region is the emerging market for the allergy
vaccine market. Based on the stats provided by the Asia Pacific Association of
Allergy (APAAACI) in Asia-Pacific, the prevalence of allergic rhinitis is
variously reported as ranging from around 8–10% of the population in Korea to
more than 50% among adults in Vietnam and Thailand.
The report on the global allergy vaccine market covers segments such
as allergy type, and vaccine type. On the basis of allergy type, the
sub-markets include allergic asthma, peanut hypersensitivity, seasonal allergic
rhinitis, grass pollen hypersensitivity, tree pollen hypersensitivity, cat
dander allergy, and other allergy types. On the basis of vaccine type, the
sub-markets include cat allergy vaccine, peanut allergy vaccine, house dust
mite allergy vaccine, injectable MPL allergy vaccine, ragweed allergy
immunotherapy vaccine, and other vaccine types.
The report provides profiles of the companies in the market such
as Circassia, Cytos Biotechnology AG, DBV Technologies SA, Allertein
Therapeutics, Stallergenes Greer plc, Merck & Co., Inc., Allergy
Therapeutics, and Novartis International AG.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of allergy vaccine
market. Moreover, the study highlights current market trends and provides
forecast from 2019-2025. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.